Report cover image

Global Nuclear Medicine Radiopharmaceutic Market Research Report 2025(Status and Outlook)

Publisher Bosson Research
Published Nov 06, 2025
Length 153 Pages
SKU # BOSS20731980

Description

Report Overview

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

The global Nuclear Medicine Radiopharmaceutic market size was estimated at USD 8789.0 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.60% during the forecast period.

This report provides a deep insight into the global Nuclear Medicine Radiopharmaceutic market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Nuclear Medicine Radiopharmaceutic Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Nuclear Medicine Radiopharmaceutic market in any manner.

Global Nuclear Medicine Radiopharmaceutic Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

GE Healthcare_x000D_

Bracco Imaging_x000D_

Mallinckrodt_x000D_

Lantheus Medical Imaging_x000D_

Bayer_x000D_

Jubilant Pharma_x000D_

Nordion_x000D_

Eli Lilly_x000D_

SIEMENS_x000D_

China Isotope & Radiation_x000D_

Yantai Dongcheng Biochemicals

Market Segmentation (by Type)

Tc-99_x000D_

I-123/131_x000D_

In-111_x000D_

Xe-133_x000D_

Th-201_x000D_

Ga-67_x000D_

Other

Market Segmentation (by Application)

Diagnostic_x000D_

Therapeutic

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Nuclear Medicine Radiopharmaceutic Market

Overview of the regional outlook of the Nuclear Medicine Radiopharmaceutic Market:

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Nuclear Medicine Radiopharmaceutic Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Nuclear Medicine Radiopharmaceutic, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors

You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

Provision of market value data for each segment and sub-segment

Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis

Provides insight into the market through Value Chain

Market dynamics scenario, along with growth opportunities of the market in the years to come

Table of Contents

153 Pages
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Nuclear Medicine Radiopharmaceutic
1.2 Key Market Segments
1.2.1 Nuclear Medicine Radiopharmaceutic Segment by Type
1.2.2 Nuclear Medicine Radiopharmaceutic Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Nuclear Medicine Radiopharmaceutic Market Overview
2.1 Global Market Overview
2.1.1 Global Nuclear Medicine Radiopharmaceutic Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Nuclear Medicine Radiopharmaceutic Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Nuclear Medicine Radiopharmaceutic Market Competitive Landscape
3.1 Company Assessment Quadrant
3.2 Global Nuclear Medicine Radiopharmaceutic Product Life Cycle
3.3 Global Nuclear Medicine Radiopharmaceutic Sales by Manufacturers (2020-2025)
3.4 Global Nuclear Medicine Radiopharmaceutic Revenue Market Share by Manufacturers (2020-2025)
3.5 Nuclear Medicine Radiopharmaceutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Nuclear Medicine Radiopharmaceutic Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Nuclear Medicine Radiopharmaceutic Market Competitive Situation and Trends
3.8.1 Nuclear Medicine Radiopharmaceutic Market Concentration Rate
3.8.2 Global 5 and 10 Largest Nuclear Medicine Radiopharmaceutic Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 Nuclear Medicine Radiopharmaceutic Industry Chain Analysis
4.1 Nuclear Medicine Radiopharmaceutic Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Nuclear Medicine Radiopharmaceutic Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Nuclear Medicine Radiopharmaceutic Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy – April 2025
5.6.3 Global Trade Frictions and Their Impacts to Nuclear Medicine Radiopharmaceutic Market
5.7 ESG Ratings of Leading Companies
6 Nuclear Medicine Radiopharmaceutic Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Nuclear Medicine Radiopharmaceutic Sales Market Share by Type (2020-2025)
6.3 Global Nuclear Medicine Radiopharmaceutic Market Size Market Share by Type (2020-2025)
6.4 Global Nuclear Medicine Radiopharmaceutic Price by Type (2020-2025)
7 Nuclear Medicine Radiopharmaceutic Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Nuclear Medicine Radiopharmaceutic Market Sales by Application (2020-2025)
7.3 Global Nuclear Medicine Radiopharmaceutic Market Size (M USD) by Application (2020-2025)
7.4 Global Nuclear Medicine Radiopharmaceutic Sales Growth Rate by Application (2020-2025)
8 Nuclear Medicine Radiopharmaceutic Market Sales by Region
8.1 Global Nuclear Medicine Radiopharmaceutic Sales by Region
8.1.1 Global Nuclear Medicine Radiopharmaceutic Sales by Region
8.1.2 Global Nuclear Medicine Radiopharmaceutic Sales Market Share by Region
8.2 Global Nuclear Medicine Radiopharmaceutic Market Size by Region
8.2.1 Global Nuclear Medicine Radiopharmaceutic Market Size by Region
8.2.2 Global Nuclear Medicine Radiopharmaceutic Market Size Market Share by Region
8.3 North America
8.3.1 North America Nuclear Medicine Radiopharmaceutic Sales by Country
8.3.2 North America Nuclear Medicine Radiopharmaceutic Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Nuclear Medicine Radiopharmaceutic Sales by Country
8.4.2 Europe Nuclear Medicine Radiopharmaceutic Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Nuclear Medicine Radiopharmaceutic Sales by Region
8.5.2 Asia Pacific Nuclear Medicine Radiopharmaceutic Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Nuclear Medicine Radiopharmaceutic Sales by Country
8.6.2 South America Nuclear Medicine Radiopharmaceutic Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Nuclear Medicine Radiopharmaceutic Sales by Region
8.7.2 Middle East and Africa Nuclear Medicine Radiopharmaceutic Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 Nuclear Medicine Radiopharmaceutic Market Production by Region
9.1 Global Production of Nuclear Medicine Radiopharmaceutic by Region(2020-2025)
9.2 Global Nuclear Medicine Radiopharmaceutic Revenue Market Share by Region (2020-2025)
9.3 Global Nuclear Medicine Radiopharmaceutic Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Nuclear Medicine Radiopharmaceutic Production
9.4.1 North America Nuclear Medicine Radiopharmaceutic Production Growth Rate (2020-2025)
9.4.2 North America Nuclear Medicine Radiopharmaceutic Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Nuclear Medicine Radiopharmaceutic Production
9.5.1 Europe Nuclear Medicine Radiopharmaceutic Production Growth Rate (2020-2025)
9.5.2 Europe Nuclear Medicine Radiopharmaceutic Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Nuclear Medicine Radiopharmaceutic Production (2020-2025)
9.6.1 Japan Nuclear Medicine Radiopharmaceutic Production Growth Rate (2020-2025)
9.6.2 Japan Nuclear Medicine Radiopharmaceutic Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Nuclear Medicine Radiopharmaceutic Production (2020-2025)
9.7.1 China Nuclear Medicine Radiopharmaceutic Production Growth Rate (2020-2025)
9.7.2 China Nuclear Medicine Radiopharmaceutic Production, Revenue, Price and Gross Margin (2020-2025)
10 Key Companies Profile
10.1 GE Healthcare_x000D_
10.1.1 GE Healthcare_x000D_ Basic Information
10.1.2 GE Healthcare_x000D_ Nuclear Medicine Radiopharmaceutic Product Overview
10.1.3 GE Healthcare_x000D_ Nuclear Medicine Radiopharmaceutic Product Market Performance
10.1.4 GE Healthcare_x000D_ Business Overview
10.1.5 GE Healthcare_x000D_ SWOT Analysis
10.1.6 GE Healthcare_x000D_ Recent Developments
10.2 Bracco Imaging_x000D_
10.2.1 Bracco Imaging_x000D_ Basic Information
10.2.2 Bracco Imaging_x000D_ Nuclear Medicine Radiopharmaceutic Product Overview
10.2.3 Bracco Imaging_x000D_ Nuclear Medicine Radiopharmaceutic Product Market Performance
10.2.4 Bracco Imaging_x000D_ Business Overview
10.2.5 Bracco Imaging_x000D_ SWOT Analysis
10.2.6 Bracco Imaging_x000D_ Recent Developments
10.3 Mallinckrodt_x000D_
10.3.1 Mallinckrodt_x000D_ Basic Information
10.3.2 Mallinckrodt_x000D_ Nuclear Medicine Radiopharmaceutic Product Overview
10.3.3 Mallinckrodt_x000D_ Nuclear Medicine Radiopharmaceutic Product Market Performance
10.3.4 Mallinckrodt_x000D_ Business Overview
10.3.5 Mallinckrodt_x000D_ SWOT Analysis
10.3.6 Mallinckrodt_x000D_ Recent Developments
10.4 Lantheus Medical Imaging_x000D_
10.4.1 Lantheus Medical Imaging_x000D_ Basic Information
10.4.2 Lantheus Medical Imaging_x000D_ Nuclear Medicine Radiopharmaceutic Product Overview
10.4.3 Lantheus Medical Imaging_x000D_ Nuclear Medicine Radiopharmaceutic Product Market Performance
10.4.4 Lantheus Medical Imaging_x000D_ Business Overview
10.4.5 Lantheus Medical Imaging_x000D_ Recent Developments
10.5 Bayer_x000D_
10.5.1 Bayer_x000D_ Basic Information
10.5.2 Bayer_x000D_ Nuclear Medicine Radiopharmaceutic Product Overview
10.5.3 Bayer_x000D_ Nuclear Medicine Radiopharmaceutic Product Market Performance
10.5.4 Bayer_x000D_ Business Overview
10.5.5 Bayer_x000D_ Recent Developments
10.6 Jubilant Pharma_x000D_
10.6.1 Jubilant Pharma_x000D_ Basic Information
10.6.2 Jubilant Pharma_x000D_ Nuclear Medicine Radiopharmaceutic Product Overview
10.6.3 Jubilant Pharma_x000D_ Nuclear Medicine Radiopharmaceutic Product Market Performance
10.6.4 Jubilant Pharma_x000D_ Business Overview
10.6.5 Jubilant Pharma_x000D_ Recent Developments
10.7 Nordion_x000D_
10.7.1 Nordion_x000D_ Basic Information
10.7.2 Nordion_x000D_ Nuclear Medicine Radiopharmaceutic Product Overview
10.7.3 Nordion_x000D_ Nuclear Medicine Radiopharmaceutic Product Market Performance
10.7.4 Nordion_x000D_ Business Overview
10.7.5 Nordion_x000D_ Recent Developments
10.8 Eli Lilly_x000D_
10.8.1 Eli Lilly_x000D_ Basic Information
10.8.2 Eli Lilly_x000D_ Nuclear Medicine Radiopharmaceutic Product Overview
10.8.3 Eli Lilly_x000D_ Nuclear Medicine Radiopharmaceutic Product Market Performance
10.8.4 Eli Lilly_x000D_ Business Overview
10.8.5 Eli Lilly_x000D_ Recent Developments
10.9 SIEMENS_x000D_
10.9.1 SIEMENS_x000D_ Basic Information
10.9.2 SIEMENS_x000D_ Nuclear Medicine Radiopharmaceutic Product Overview
10.9.3 SIEMENS_x000D_ Nuclear Medicine Radiopharmaceutic Product Market Performance
10.9.4 SIEMENS_x000D_ Business Overview
10.9.5 SIEMENS_x000D_ Recent Developments
10.10 China Isotope and Radiation_x000D_
10.10.1 China Isotope and Radiation_x000D_ Basic Information
10.10.2 China Isotope and Radiation_x000D_ Nuclear Medicine Radiopharmaceutic Product Overview
10.10.3 China Isotope and Radiation_x000D_ Nuclear Medicine Radiopharmaceutic Product Market Performance
10.10.4 China Isotope and Radiation_x000D_ Business Overview
10.10.5 China Isotope and Radiation_x000D_ Recent Developments
10.11 Yantai Dongcheng Biochemicals
10.11.1 Yantai Dongcheng Biochemicals Basic Information
10.11.2 Yantai Dongcheng Biochemicals Nuclear Medicine Radiopharmaceutic Product Overview
10.11.3 Yantai Dongcheng Biochemicals Nuclear Medicine Radiopharmaceutic Product Market Performance
10.11.4 Yantai Dongcheng Biochemicals Business Overview
10.11.5 Yantai Dongcheng Biochemicals Recent Developments
11 Nuclear Medicine Radiopharmaceutic Market Forecast by Region
11.1 Global Nuclear Medicine Radiopharmaceutic Market Size Forecast
11.2 Global Nuclear Medicine Radiopharmaceutic Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Nuclear Medicine Radiopharmaceutic Market Size Forecast by Country
11.2.3 Asia Pacific Nuclear Medicine Radiopharmaceutic Market Size Forecast by Region
11.2.4 South America Nuclear Medicine Radiopharmaceutic Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Nuclear Medicine Radiopharmaceutic by Country
12 Forecast Market by Type and by Application (2026-2033)
12.1 Global Nuclear Medicine Radiopharmaceutic Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Nuclear Medicine Radiopharmaceutic by Type (2026-2033)
12.1.2 Global Nuclear Medicine Radiopharmaceutic Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Nuclear Medicine Radiopharmaceutic by Type (2026-2033)
12.2 Global Nuclear Medicine Radiopharmaceutic Market Forecast by Application (2026-2033)
12.2.1 Global Nuclear Medicine Radiopharmaceutic Sales (K MT) Forecast by Application
12.2.2 Global Nuclear Medicine Radiopharmaceutic Market Size (M USD) Forecast by Application (2026-2033)
13 Conclusion and Key Findings
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.